Effect of integrin α5β1 inhibition on SDF-l/CXCR4-mediated choroidal neovascularization

Yang Lyu1,2, Wen-Qin Xu1, Li-Juan Sun1

  • 1Department of Ophthalmology, Eye Institute of China PLA, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, Shaanxi Province, China.

Abstract

Insights

Stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 promote choroidal neovascularization (CNV) by increasing integrin α5β1 expression in endothelial cells. Inhibiting CXCR4 or integrin α5β1 effectively reduces CNV progression.

Area of Science:

  • Ophthalmology
  • Vascular Biology
  • Cell Signaling

Background:

  • Choroidal neovascularization (CNV) is a major cause of vision loss.
  • The stromal cell-derived factor-1 (SDF-1)/CXCR4 axis and integrins are implicated in CNV pathogenesis.

Purpose of the Study:

  • To investigate the role of integrins in CNV.
  • To explore the association between integrins and the SDF-1/CXCR4 axis in CNV.

Main Methods:

  • CNV was induced in mice using laser photocoagulation.
  • Animals were treated with SDF-1, a CXCR4 inhibitor (AMD3100), or an integrin α5β1 inhibitor (ATN161).
  • CNV progression was assessed using HE staining, FFA, and OCT; protein expression was analyzed via Western blot and immunofluorescence. In vitro studies used hypoxia-exposed endothelial cells.

Main Results:

  • SDF-1 treatment significantly promoted CNV progression.
  • Inhibitors of CXCR4 (AMD3100) and integrin α5β1 (ATN161) significantly reduced CNV size, thickness, and leakage.
  • SDF-1 increased integrin α5 and CXCR4 expression in vivo and in vitro; AMD3100 and ATN161 treatments decreased these levels and inhibited endothelial cell migration and tube formation.

Conclusions:

  • SDF-1/CXCR4 signaling drives CNV by upregulating integrin α5β1 expression in endothelial cells.
  • Targeting the SDF-1/CXCR4 axis or integrin α5β1 presents a potential therapeutic strategy for CNV.

Related Concept Videos

Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
5.5K
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
5.2K
Feedback Inhibition00:46

Feedback Inhibition

Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
57.3K
Enzyme Inhibition01:30

Enzyme Inhibition

Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
92.7K
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
6.0K
Receptor-mediated Endocytosis01:39

Receptor-mediated Endocytosis

Overview
111.1K